Unravelling the pathogenesis of myasthenia gravis, Nat Rev Immunol, vol.2, pp.797-804, 2002. ,
Diagnostic and clinical classification of autoimmune myasthenia gravis, J Autoimmun, pp.143-151, 2014. ,
Pathogenesis of myasthenia gravis: update on disease types, models, and mechanisms, vol.5, pp.1-10, 2016. ,
Direct proof of the in vivo pathogenic role of the AChR autoantibodies from myasthenia gravis patients, PLoS ONE, vol.9, p.108327, 2014. ,
Autoantibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies, Nat Med, vol.7, pp.365-373, 2001. ,
Anti-LRP4 autoantibodies in AChR-and MuSKantibody-negative myasthenia gravis, J Neurol, vol.259, pp.427-462, 2012. ,
Autoantibodies to lipoprotein-related protein 4 in patients with double-seronegative myasthenia gravis, Arch Neurol, vol.69, pp.445-51, 2012. ,
Autoimmune response to acetylcholine receptor, Science, vol.180, pp.871-873, 1973. ,
Estrogen enhances susceptibility to experimental autoimmune myasthenia gravis by promoting type 1-polarized immune responses, J Immunol, vol.175, pp.5050-5057, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00458865
Genetic factors in autoimmune myasthenia gravis, Ann N Y Acad Sci, vol.1132, pp.180-92, 2008. ,
A genome-wide association study of myasthenia gravis, JAMA Neurol, vol.72, pp.396-404, 2015. ,
Association of the PTPN22 * R620W polymorphism with autoimmune myasthenia gravis, Ann Neurol, vol.59, pp.404-411, 2006. ,
The autoimmunity-related polymorphism PTPN22 1858C/T is associated with anti-titin antibody-positive myasthenia gravis, Hum Immunol, vol.70, pp.540-542, 2009. ,
Risk for myasthenia gravis maps to a (151) Pro->Ala change in TNIP1 and to human leukocyte antigen-B * 08, Ann Neurol, vol.72, pp.927-962, 2012. ,
CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis, Genes Immun, vol.3, pp.46-55, 2002. ,
A CTLA4high genotype is associated with myasthenia gravis in thymoma patients, Ann Neurol, vol.58, pp.644-652, 2005. ,
VAV1 and BAFF, via NFkappaB pathway, are genetic risk factors for myasthenia gravis, Ann Clin Transl Neurol, vol.1, pp.329-368, 2014. ,
Defective T-cell receptor signalling and positive selection of Vav-deficient CD4 + CD8 + thymocytes, Nature, vol.374, pp.474-481, 1995. ,
Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav, Nature, vol.374, pp.467-70, 1995. ,
Defective signalling through the T-and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene, Nature, vol.374, pp.470-473, 1995. ,
A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes, Immunity, vol.7, pp.451-60, 1997. ,
Vav-family proteins in T-cell signalling, Curr Opin Immunol, vol.17, pp.267-74, 2005. ,
Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor, Curr Biol, vol.8, pp.554-62, 1998. ,
The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways, Proc Natl Acad Sci, vol.96, pp.3035-3075, 1999. ,
Function of the nucleotide exchange activity of vav1 in T cell development and activation, Sci Signal, vol.2, p.83, 2009. ,
A natural variant of the T cell receptor-signaling molecule Vav1 reduces both effector T cell functions and susceptibility to neuroinflammation, PLoS Genet, vol.12, p.1006185, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01438135
The p.Arg63Trp polymorphism controls Vav1 functions and Foxp3 regulatory T cell development, J Exp Med, vol.208, pp.2183-91, 2011. ,
Production and assay of antibodies to acetylcholine receptors, Methods Enzymol, pp.432-60, 1981. ,
Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1-or Th2-type immune response in rats, J Immunol, vol.162, pp.7189-97, 1999. ,
Disruption of the IL-1beta gene diminishes acetylcholine receptor-induced immune responses in a murine model of myasthenia gravis, Eur J Immunol, vol.31, pp.225-257, 2001. ,
The susceptibility to experimental myasthenia gravis of STAT6 ?/? and STAT4 ?/? BALB/c mice suggests a pathogenic role of Th1 cells, J Immunol, vol.172, pp.97-103, 2004. ,
Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice, J Exp Med, vol.186, pp.385-91, 1997. ,
IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease, Eur J Immunol, vol.28, pp.2487-97, 1998. ,
Increased serum interleukin-17 levels in patients with myasthenia gravis, Muscle Nerve, vol.44, pp.278-80, 2011. ,
IL-17-producing CD4(+) T cells contribute to the loss of B-cell tolerance in experimental autoimmune myasthenia gravis, Eur J Immunol, vol.45, pp.1339-1386, 2015. ,
Autoreactive T cells from patients with myasthenia gravis are characterized by elevated IL-17, IFN-gamma, and GM-CSF and diminished IL-10 production, J Immunol, vol.196, pp.2075-84, 2016. ,
Ablation of IL-17 expression moderates experimental autoimmune myasthenia gravis disease severity, Cytokine, vol.96, pp.279-85, 2017. ,
Early signaling events that underlie fate decisions of naive CD4(+) T cells toward distinct T-helper cell subsets, Immunol Rev, vol.252, pp.12-23, 2013. ,
TCR signal quantity and quality in CD4(+) T cell differentiation, Trends Immunol, vol.35, pp.591-597, 2014. ,
T-cell-receptor-dependent signal intensity dominantly controls CD4(+) T cell polarization in vivo, Immunity, vol.41, pp.63-74, 2014. ,
Role of TCR-induced extracellular signal-regulated kinase activation in the regulation of early IL-4 expression in naive CD4(+) T cells, J Immunol, vol.170, pp.2427-2461, 2003. ,
Independent roles for IL-2 and GATA-3 in stimulating naive CD4(+) T cells to generate a Th2-inducing cytokine environment, J Exp Med, vol.202, pp.793-804, 2005. ,
Duration of TCR signaling controls CD4-CD8 lineage differentiation in vivo, Nat Immunol, vol.5, pp.280-288, 2004. ,
A role for VAV1 in experimental autoimmune encephalomyelitis and multiple sclerosis, Sci Transl Med, vol.1, pp.10-21, 2009. ,
VAV1 regulates experimental autoimmune arthritis and is associated with anti-CCP negative rheumatoid arthritis, Genes Immun, vol.18, pp.48-56, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02084423